IMAC Holdings faces potential delisting from Nasdaq due to regulatory compliance failures.

IMAC Holdings, a Tennessee-based medical company, received notices from Nasdaq for failing to meet listing rules, including a delayed quarterly report filing. The company must submit a plan to regain compliance by January 21, 2024, with possible extensions up to 180 days. IMAC is working to rectify the issues and avoid delisting.

November 23, 2024
3 Articles

Further Reading